As the GRO-α receptor CXCR2 is expressed in all bladder cancer cells irrespective of the mesenchymal phenotype, it is probable that secretion of GRO-α is associated with bladder cancer recurrence via an autocrine loop involving its receptor. Here, CXCR2 is linked to urinary bladder cancer.